Insights On CONTRACT PHARMA MANUFACTURING

  1. Boehringer Ingelheim Large Scale Cell Culture Facility 3/14/2025

    With cutting-edge innovations like smart glasses for live process insights and a data-sharing portal, we're able to provide the capacity and expertise to bring biologics to commercial success.

  2. Emerging Trends In The CDMO Landscape With Bend Bioscience 3/14/2025

    In this interview, Michael discusses how the company is adapting to emerging trends in the CDMO landscape, driving innovation, and enhancing pharmaceutical product development.

  3. Phase-Appropriate Approaches To Manufacturing And Testing 3/14/2025

    Accelerate the development of high-quality biopharmaceuticals by implementing phase-appropriate, risk-based manufacturing and testing strategies that ensure timely progression.

  4. Analytical Method Release And Stability Platform For RNA Drug Substance 3/14/2025

    We offer comprehensive analytical support across the R&D space, including method development, validation, process characterization, in-process testing, process validation, and GMP release testing.

  5. Smart Scale-Up: Expanding Viral Vectors With Microcarrier Bead Technology 3/12/2025

    Scale up your manufacturing of adherent cell cultures used for viral vector-based treatments with the novel technologies needed to facilitate safe, rapid production.

  6. Supply-Chain Statistics And Realistic Outsourcing Options 3/12/2025

    Kishore Hotha, President, Dr. Hotha’s Life Sciences, provides some telling stats that should inform outsourcing decision-making in the coming months… and perhaps years.

  7. Remind Me: Why Are We At Biotech War With China? 3/12/2025

    It’s hard to focus on the issues that precipitated the challenges and proscribed solutions to so much of our supply chain being in China. IP was (and should be) at the center of the discussion.

  8. Good 'Supplier Hygiene' Before And After COVID And The BIOSECURE Act 3/12/2025

    Can you recall the fundamentals of outsourcing development and manufacturing five or 10 years ago, if you were in the industry then? Our panel can, and it’s instructive to take the trip back in time.

  9. Smaller Biotechs Take Bigger Hits 3/12/2025

    Our panel of experienced biopharma executives explain the different effects on trade wars or supply-chain disruptions with Big Pharma and smaller drug development organizations.

  10. Can We Actually Decouple US-China Supply-Chain Integration? 3/12/2025

    The realities in 2024 suggest the answer is no, and our panel of speakers detail why that is the right answer.